申请人:Ban Hitoshi
公开号:US20080096922A1
公开(公告)日:2008-04-24
A compound of the formula (1):
wherein
m, n and p is independently an integer of 0 to 4 with the proviso that 3≦m+n≦8; X is the formula: NR
4
, etc.; R
1
, R
3
and R
4
are a substituted or unsubstituted aryl group, etc.; R
2
is a hydrogen atom, etc.; a, b, c, d, e and f are a hydrogen atom or a substituted or unsubstituted alkyl group, etc.; Y is the formula: —SO
2
—, etc.; and Z is an oxygen atom, etc.;
or a prodrug thereof or a pharmaceutically acceptable salt of the same has an activity of potentiating an expression of a low density lipoprotein receptor and thus is useful as an agent for treating hyperlipidemia or arteriosclerosis.
公式(1)的化合物:
其中,m,n和p分别为0至4的整数,但须满足3≦m+n≦8;X为公式:NR4等;R1,R3和R4为取代或未取代的芳基基团等;R2为氢原子等;a,b,c,d,e和f为氢原子或取代或未取代的烷基基团等;Y为公式:—SO2—等;Z为氧原子等;或其前体药物或其药学上可接受的盐具有增强低密度脂蛋白受体表达的活性,因此可用作治疗高脂血症或动脉硬化的药物。